N Acetyl Cysteine: Clinical Trials

5 trials of N Acetyl Cysteine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 recruiting, 1 terminated. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 22Recruiting 1, Unknown 1

Follow N Acetyl Cysteine: new trials by email Literature Review of N Acetyl Cysteine trials Research Report on N Acetyl Cysteine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion
N Acetyl Cysteine, Vitamin D (Cholecalciferol ), control group - Corrosive Injury
Phase 3Active not recruitingAin Shams University802024-10-012025-11-17
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial
N acetyl cysteine, Placebo - Autism Spectrum Disorder
Phase 2 / Phase 3RecruitingStanford University1442023-04-262026-05-15
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
N acetyl cysteine - Tuberculosis, Drug Induced Liver Injury
Phase 2 / Phase 3UnknownMahidol University822022-09-092023-02-22
N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.
N acetyl cysteine - Mucositis, Transplant-Related Disorder
Phase 3Unknownmoshe yeshurun1162021-04-012021-02-16
NAC for Head Trauma-induced Anosmia
N Acetyl Cysteine, Placebo oral capsule - Anosmia, Head Trauma
Phase 3TerminatedUniversity of Miami72018-10-122021-02-04

Conditions studied

Anosmia (1)  ·  Autism Spectrum Disorder (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Craniocerebral Trauma (1)  ·  Hepatitis (1)  ·  Mucositis (1)  ·  Tuberculosis (1)

Sponsors

Ain Shams University (1)  ·  Mahidol University (1)  ·  Stanford University (1)  ·  University of Miami (1)  ·  moshe yeshurun (1)

Countries

United States (2)  ·  Egypt (1)  ·  Thailand (1)

Top investigators

Eglal H Elawady, Professor of toxicology (1)  ·  John Hegarty, PhD (1)  ·  Roy Casiano, MD (1)  ·  Supot Nimanong, MD (1)  ·  Walaa G Abdelhamid, Assistant Professor (1)

NIH funding

R00HD101702 (1)